284 related articles for article (PubMed ID: 26491664)
1. The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease.
Arias-Loste MT; Fábrega E; López-Hoyos M; Crespo J
Biomed Res Int; 2015; 2015():319745. PubMed ID: 26491664
[TBL] [Abstract][Full Text] [Related]
2. Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways.
Kang HH; Kim IK; Lee HI; Joo H; Lim JU; Lee J; Lee SH; Moon HS
Biochem Biophys Res Commun; 2017 Aug; 490(2):349-355. PubMed ID: 28623125
[TBL] [Abstract][Full Text] [Related]
3. Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms.
Musso G; Olivetti C; Cassader M; Gambino R
Semin Liver Dis; 2012 Feb; 32(1):49-64. PubMed ID: 22418888
[TBL] [Abstract][Full Text] [Related]
4. OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease.
Paschetta E; Belci P; Alisi A; Liccardo D; Cutrera R; Musso G; Nobili V
Mediators Inflamm; 2015; 2015():815721. PubMed ID: 25873773
[TBL] [Abstract][Full Text] [Related]
5. Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway.
Zhang H; Zhou L; Zhou Y; Wang L; Jiang W; Liu L; Yue S; Zheng P; Liu H
Life Sci; 2021 Nov; 285():119963. PubMed ID: 34536498
[TBL] [Abstract][Full Text] [Related]
6. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.
Nobili V; Cutrera R; Liccardo D; Pavone M; Devito R; Giorgio V; Verrillo E; Baviera G; Musso G
Am J Respir Crit Care Med; 2014 Jan; 189(1):66-76. PubMed ID: 24256086
[TBL] [Abstract][Full Text] [Related]
7. Liver immune responses to inflammatory stimuli in a diet-induced obesity model of zebrafish.
Forn-Cuní G; Varela M; Fernández-Rodríguez CM; Figueras A; Novoa B
J Endocrinol; 2015 Feb; 224(2):159-70. PubMed ID: 25371540
[TBL] [Abstract][Full Text] [Related]
8. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL
J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease and obstructive sleep apnea.
Aron-Wisnewsky J; Clement K; Pépin JL
Metabolism; 2016 Aug; 65(8):1124-35. PubMed ID: 27324067
[TBL] [Abstract][Full Text] [Related]
10. What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa?
Tarantino G; Citro V; Finelli C
J Gastrointestin Liver Dis; 2014 Sep; 23(3):291-9. PubMed ID: 25267958
[TBL] [Abstract][Full Text] [Related]
11. Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia.
Türkay C; Ozol D; Kasapoğlu B; Kirbas I; Yıldırım Z; Yiğitoğlu R
Respir Care; 2012 Feb; 57(2):244-9. PubMed ID: 21762556
[TBL] [Abstract][Full Text] [Related]
12. Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease.
Ji Y; Liang Y; Mak JCW; Ip MSM
Sleep Med; 2022 Jul; 95():16-28. PubMed ID: 35537279
[TBL] [Abstract][Full Text] [Related]
13. Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease.
Chen Z; Yu Y; Cai J; Li H
Trends Endocrinol Metab; 2019 Dec; 30(12):903-914. PubMed ID: 31597607
[TBL] [Abstract][Full Text] [Related]
14. Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease.
Mesarwi OA; Loomba R; Malhotra A
Am J Respir Crit Care Med; 2019 Apr; 199(7):830-841. PubMed ID: 30422676
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease.
Haas JT; Francque S; Staels B
Annu Rev Physiol; 2016; 78():181-205. PubMed ID: 26667070
[TBL] [Abstract][Full Text] [Related]
16. [Changes of serum aminotransferase in children with obstructive sleep apnea hypopnea syndrome].
Chen Z; Duo L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Aug; 27(15):809-12. PubMed ID: 24364104
[TBL] [Abstract][Full Text] [Related]
17. The impact of obstructive sleep apnea on nonalcoholic fatty liver disease.
Tang H; Lv F; Zhang P; Liu J; Mao J
Front Endocrinol (Lausanne); 2023; 14():1254459. PubMed ID: 37850091
[TBL] [Abstract][Full Text] [Related]
18. Obstructive Sleep Apnea Syndrome and Metabolic Diseases.
Li M; Li X; Lu Y
Endocrinology; 2018 Jul; 159(7):2670-2675. PubMed ID: 29788220
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease.
Bibbò S; Ianiro G; Dore MP; Simonelli C; Newton EE; Cammarota G
Mediators Inflamm; 2018; 2018():9321643. PubMed ID: 29563854
[TBL] [Abstract][Full Text] [Related]
20. The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
Almeda-Valdes P; Aguilar Olivos NE; Barranco-Fragoso B; Uribe M; Méndez-Sánchez N
Biomed Res Int; 2015; 2015():768071. PubMed ID: 26339640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
